Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 71.21%219.52B | 5.99%695.42B | 3.52%128.22B | 23.87%656.13B | -19.22%153.38B | 108.08%230.95B | 28.88%147.94B | 8.61%123.85B | -4.53%529.7B | 14.89%189.88B |
| Cost of revenue | 80.17%198.16B | 4.56%609.08B | 1.47%109.99B | 24.38%582.51B | -24.22%133.47B | 123.33%211.82B | 29.70%128.82B | 10.56%108.4B | -6.38%468.33B | 17.82%176.12B |
| Gross profit | 17.15%21.35B | 17.28%86.34B | 17.92%18.23B | 19.97%73.62B | 44.69%19.91B | 18.49%19.13B | 23.63%19.13B | -3.35%15.46B | 12.53%61.37B | -12.81%13.76B |
| Operating expense | 17.62%9.71B | 9.58%37.38B | -0.01%8.26B | 15.19%34.11B | 19.94%10.46B | 16.61%7.93B | 11.87%7.47B | 11.31%8.26B | -19.19%29.61B | -44.22%8.72B |
| Operating profit | 16.76%11.64B | 23.93%48.97B | 38.49%9.97B | 24.42%39.51B | 87.54%9.45B | 19.85%11.2B | 32.55%11.66B | -16.03%7.2B | 77.47%31.76B | 3,304.73%5.04B |
| Net non-operating interest income (expenses) | -38.30%-1.32B | -65.51%-4.38B | -82.22%-953M | -32.60%-2.64B | 44.21%-390M | -95.03%-1.14B | -42.45%-594M | -77.29%-523M | -42.84%-1.99B | -164.77%-699M |
| Non-operating interest income | 285.71%162M | 109.79%300M | 82.61%42M | 694.44%143M | 388.89%44M | -133.33%-2M | 2,500.00%78M | --23M | 500.00%18M | 800.00%9M |
| Non-operating interest expense | 48.74%1.48B | 67.78%4.68B | 82.23%995M | 72.78%2.79B | 66.08%847M | 64.09%722M | 82.61%672M | 85.08%546M | 68.02%1.61B | 96.15%510M |
| Total other finance cost | ---- | ---- | ---- | 40.10%559M | -26.26%146M | ---- | ---- | ---- | -9.11%399M | 3,860.00%198M |
| Net investment income | -50.00%96M | -3.15%3.57B | -74.67%192M | 884.76%3.68B | 3,475.47%1.9B | -7.50%37M | 646.62%993M | 412.16%758M | -69.57%374M | -94.08%53M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 4,737.50%1.94B | 92.90%353M | -4.76%40M | 163.32%183M | 1,775.00%67M | 1,233.33%34M | 111.83%40M | -25.00%42M | -276.22%-289M | -200.00%-4M |
| Income from associates and other participating interests | 91.26%6.93B | 71.80%18.01B | 57.61%3.63B | 7.86%10.48B | 87.27%1.87B | -2.43%3.69B | 38.38%2.63B | -24.42%2.3B | 377.54%9.72B | 125.38%998M |
| Special income (charges) | -697M | 0 | 0 | 216M | -9M | |||||
| Less:Restructuring and mergern&acquisition | ---- | --697M | ---- | --0 | --0 | ---- | ---- | ---- | ---225M | --0 |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9M | ---- |
| Other non-operating income (expenses) | 123.80%1.12B | 138.52%52M | 101.61%500M | -152.73%-135M | -28,171.43%-1.97B | 435.35%530M | 1,198.77%1.05B | 259.42%248M | -14.95%256M | -93.75%7M |
| Income before tax | 52.55%20.4B | 28.96%65.87B | 33.43%13.38B | 27.59%51.08B | 102.93%10.93B | 11.22%14.35B | 55.39%15.78B | -13.54%10.02B | 97.93%40.04B | 277.22%5.38B |
| Income tax | 59.98%4.9B | 50.10%20.98B | 5.08%3.06B | 32.00%13.98B | 77.39%2.9B | 18.37%4.09B | 67.57%4.08B | -5.05%2.91B | 125.88%10.59B | 322.95%1.63B |
| Net income | 50.36%15.51B | 21.00%44.9B | 45.03%10.31B | 25.99%37.1B | 114.02%8.03B | 8.61%10.26B | 51.51%11.7B | -16.59%7.11B | 89.50%29.45B | 262.64%3.75B |
| Net income continuous operations | 50.35%15.51B | 21.00%44.9B | 45.04%10.31B | 26.00%37.11B | 114.05%8.03B | 8.60%10.26B | 51.54%11.7B | -16.60%7.11B | 89.50%29.45B | 262.71%3.75B |
| Noncontrolling interests | -52.45%282M | 51.73%2.86B | 107.34%593M | 79.33%1.88B | 253.15%392M | 107.19%576M | 127.90%629M | -25.71%286M | 64.58%1.05B | -0.89%111M |
| Net income attributable to the company | 56.63%15.22B | 19.36%42.04B | 42.44%9.72B | 24.02%35.22B | 109.78%7.64B | 5.61%9.69B | 48.69%11.07B | -16.16%6.82B | 90.57%28.4B | 250.58%3.64B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 56.63%15.22B | 19.36%42.04B | 42.44%9.72B | 24.02%35.22B | 109.78%7.64B | 5.61%9.69B | 48.69%11.07B | -16.16%6.82B | 90.57%28.4B | 250.58%3.64B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 38.96%54.39 | 6.53%154.54 | 38.82%39.14 | 23.62%145.07 | 108.90%31.414 | 5.16%39.856 | 48.26%45.606 | -16.22%28.194 | 90.46%117.35 | 250.41%15.038 |
| Diluted earnings per share | 38.96%54.39 | 6.53%154.54 | 38.82%39.14 | 23.62%145.07 | 108.90%31.414 | 5.14%39.8494 | 48.26%45.606 | -16.22%28.194 | 90.46%117.35 | 250.41%15.038 |
| Dividend per share | 0 | 22.40%47 | 0 | 30.61%38.4 | 32.93%21.8 | 0 | 27.69%16.6 | 0 | 33.64%29.4 | 49.09%16.4 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |